Table 2. COVID-19 treatment intervention during hospitalization.
| EPIC (N = 395) % (n) |
Control (N = 446) % (n) |
P value | |
|---|---|---|---|
| Concomitant medication during hospitalization | |||
| None | 0 (0) | 0.7 (3) | 0.252a |
| Corticoids | 100 (395) | 91 (406) | <0.001 |
| Heparin | 99.2 (392) | 91.9 (410) | <0.001 |
| Convalescent plasma | 0 (0) | 71.1 (317) | <0.001 |
| Monoclonal antibodies | 0.3 (1) | 0 (0) | 0.470 a |
| Antibiotics | 69.4 (274) | 72 (321) | 0.407 |
| Ivermectin | 0 (0) | 0.2 (1) | 1.000 a |
| Tocilizumab | 0 (0) | 0.2 (1) | 1.000 a |
| Colchicine | 0 (0) | 0.2 (1) | 1.000 a |
| Remdesivir | 0.3 (1) | 0 (0) | 0.470 a |
All P values are for Chi2 except for
a Fisher’s exact test